Patents Assigned to Justus-Liebig Universitat Giessen
  • Patent number: 10501803
    Abstract: The present invention relates to a method of assessing whether a subject suffers from cancer or is prone to suffering from cancer, in particular lung cancer, comprising the measurement of the amounts of specific isoforms of GATA6 and/or NKX2-1 in a sample of said subject. Furthermore, the present invention relates to a composition for use in medicine comprising (an) inhibitor(s) of specific isoforms of GATA6 and/or NKX2-1. Additionally, the present invention relates to a kit for use in a method of assessing whether a subject suffers from cancer or is prone to suffering from cancer, in particular lung cancer.
    Type: Grant
    Filed: May 21, 2014
    Date of Patent: December 10, 2019
    Assignees: MAX-PLANCK GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V., JUSTUS-LIEBIG-UNIVERSITÄT GIESSEN
    Inventors: Guillermo Barreto, Aditi Mehta, Indrabahadur Singh, Marten Szibor, Rajkumar Savai, Werner Seeger, Thomas Braun, Andreas Günther, Marcus Krüger
  • Patent number: 9382288
    Abstract: The present invention relates to compounds derived from steroids of the general formula (I) wherein L represents a linker and R# represents a steroid residue, the use of compounds of the general formula (I) in medicine and for the prophylaxis and/or the treatment of infectious diseases. Furthermore described are pharmaceutical compositions containing at least one compound of the general formula (I). A further aspect of the invention relates to the synthesis of said compounds of the general formula (I).
    Type: Grant
    Filed: October 6, 2011
    Date of Patent: July 5, 2016
    Assignee: Justus-Liebig-Universitat Giessen
    Inventors: Katja Becker, Reimar Krieg, Bruno Schönecker
  • Patent number: 9150638
    Abstract: The present invention provides methods for treating interstitial lung diseases, comprising administering to an individual an effective amount of an inhibitor of coagulation factor XII. The invention further provides uses and pharmaceutical kits for that treatment.
    Type: Grant
    Filed: April 1, 2011
    Date of Patent: October 6, 2015
    Assignee: Justus-Liebig-Universität Giessen
    Inventors: Ewa Jablonska, Klaus Preissner, Malgorzata Wygrecka
  • Patent number: 8785641
    Abstract: The present invention describes tripodal catechol derivatives with an adamantyl basic framework for the functionalization of surfaces, methods for their production and use. The remaining fourth bridgehead position is easily suitable to be further functionalised via so-called click reactions, by way of example with biomolecules, dyes, radiomarkers, polyethylene glycol or active agents.
    Type: Grant
    Filed: September 7, 2011
    Date of Patent: July 22, 2014
    Assignee: Justus-Liebig-Universitat Giessen
    Inventors: Wolfgang Maison, Faiza Khalil, Elisa Franzmann
  • Publication number: 20140106379
    Abstract: The present invention discloses an immunological test for the detection and specific determination of autoantibodies against testicular antigens which are associated with inflammation-related fertility disorders of male mammals in a biological sample of a male mammal, in particular the detection of testicular ER-60 autoantibodies and/or transferrin autoantibodies. The immunological test is utilized to detect the presence of immunologically-caused and infection-related infertility in male mammals, particularly in humans.
    Type: Application
    Filed: September 9, 2013
    Publication date: April 17, 2014
    Applicant: JUSTUS-LIEBIG-UNIVERSITAT GIESSEN
    Inventors: ANDREAS MEINHARDT, MONIKA FIJAK
  • Patent number: 8557606
    Abstract: The present invention discloses an immunological test for the detection and specific determination of autoantibodies against testicular antigens which are associated with inflammation-related fertility disorders of male mammals in a biological sample of a male mammal, in particular the detection of testicular ER-60 autoantibodies and/or transferrin autoantibodies. The immunological test is utilized to detect the presence of immunologically-caused and infection-related infertility in male mammals, particularly in humans.
    Type: Grant
    Filed: October 22, 2009
    Date of Patent: October 15, 2013
    Assignee: Justus-Liebig-Universitat Giessen
    Inventors: Andreas Meinhardt, Monika Fijak
  • Publication number: 20130266645
    Abstract: The present invention relates to compounds derived from steroids of the general formula (I) wherein L represents a linker and R# represents a steroid residue, the use of compounds of the general formula (I) in medicine and for the prophylaxis and/or the treatment of infectious diseases. Furthermore described are pharmaceutical compositions containing at least one compound of the general formula (I). A further aspect of the invention relates to the synthesis of said compounds of the general formula (I).
    Type: Application
    Filed: October 6, 2011
    Publication date: October 10, 2013
    Applicant: Justus-Liebig-Universitat Giessen
    Inventors: Katja Becker, Reimar Krieg, Bruno Schönecker
  • Publication number: 20130267731
    Abstract: The present invention describes tripodal bisphosphonate derivatives with a flexible basic framework for the functionalisation of surfaces, and methods for their production and use. The central atom of the flexible framework is hereby a tertiary aliphatic carbon atom. A fourth remaining position of the flexible framework is suitable to be optionally functionalised by so-called click reactions, for example with biomolecules, polyethylene glycol or active agents.
    Type: Application
    Filed: September 7, 2011
    Publication date: October 10, 2013
    Applicant: JUSTUS-LIEBIG-UNIVERSITAT GIESSEN
    Inventors: Wolfgang Maison, Elisa Franzmann, Faiza Khalil
  • Publication number: 20130245270
    Abstract: The present invention describes tripodal catechol derivatives with a flexible basic framework for the functionalisation of surfaces, and methods for their production and use. The central atom of the flexible framework is hereby a tertiary aliphatic carbon atom. The remaining fourth bridgehead position is easily suitable to be further functionalised via so-called click reactions, e.g. with biomolecules, dyes, radiomarkers, polyethylene glycol or active agents.
    Type: Application
    Filed: September 7, 2011
    Publication date: September 19, 2013
    Applicant: JUSTUS-LIEBIG-UNIVERSITAT GIESSEN
    Inventors: Wolfgang Maison, Faiza Khalil, Elisa Franzmann
  • Publication number: 20130220178
    Abstract: The current invention relates to a method of making metal oxide nanoparticles comprising the reaction of—at least one metal oxide precursor (P) containing at least one metal (M) with—at least one monofunctional alcohol (A) wherein the hydroxy group is bound to a secondary, tertiary or alpha-unsaturated carbon atom—in the presence of at least one aliphatic compound (F) according to the formula Y1—R1—X—R2—Y2, wherein—R1 and R2 each are the same or different and independently selected from aliphatic groups with from 1 to 20 carbon atoms, —Y1 and Y2 each are the same or different and independently selected from OH, NH2 and SH, and —X is selected from the group consisting of chemical bond, —O—, —S—, —NR3—, and CR4R5, wherein R3, R4 and R5 each are the same or different and represent a hydrogen atom or an aliphatic group with from 1 to 20 carbon atoms which optionally carries functional groups selected from OH, NH2 and SH.
    Type: Application
    Filed: October 7, 2010
    Publication date: August 29, 2013
    Applicant: Justus-Liebig-Universitat Giessen
    Inventors: Roman Zieba, Alexander Traut, Cornelia Röger-Göpfert, Torsten Brezesinski, Bernadette Landschreiber, Claudia Grote, Georg Garnweitner, Alexandra Seeber, Bernd Smarsly, Christoph Wiedmann, Till von Graberg, Jan Haetge
  • Publication number: 20130217916
    Abstract: The present invention describes tripodal catechol derivatives with an adamantyl basic framework for the functionalisation of surfaces, and methods for their production and use. A fourth remaining position of the adamantane skeleton is suitable to be optionally functionalised by so-called click reactions, for example with biomolecules, polyethylene glycol or active agents.
    Type: Application
    Filed: September 7, 2011
    Publication date: August 22, 2013
    Applicant: JÜSTUS-LIEBIG-UNIVERSITÄT GIESSEN
    Inventors: Wolfgang Maison, Elisa Franzmann, Faiza Khalil
  • Patent number: 8491766
    Abstract: The invention at hand concerns a novel class of gas sensors, in particular for hydrogen or hydrogen-containing fluids (gases or liquids), such as hydrocarbons, hydrogen sulphides or more complex gas mixtures or gas compositions which contain hydrogen or hydrogen compounds.
    Type: Grant
    Filed: November 29, 2006
    Date of Patent: July 23, 2013
    Assignee: Justus-Liebig-Universitat Giessen
    Inventors: Baker Farangis, Bruno K. Meyer, Hans-Peter Jorde, Jennifer Stiebich
  • Publication number: 20130165625
    Abstract: The disclosed invention relates to peptides incorporating 3-aminoadamantane-1-carboxylic acids. These peptides are disclosed as surprisingly possessing neurogenic and neurotrophic properties. These pharmacological activities can advantageously be utilized for restoring or maintaining neuronal function in the CNS. In particular, the compounds can be used for treatment and prophylaxis of neurodegenerative diseases, e. g., Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, as well as in post-acute traumatic brain injury, or cerebral ischemia.
    Type: Application
    Filed: June 22, 2011
    Publication date: June 27, 2013
    Applicant: JUSTUS-LIEBIG-UNIVERSITAT GIESSEN
    Inventors: Peter R. Schreiner, Lukas Wanka
  • Publication number: 20130149535
    Abstract: The present invention provides nano-, meso- and micro-polymer particles which are able to bind pathogenic proteins penetrating into the lining layer of the lung. Known pathogenic proteins in the pulmonary lining layer are negatively charged. These proteins damage the pulmonary surfactant system which is essential to maintain a low surface tension in the lung and thus a functional respiration. Polymer particles of this invention have a diameter between 20 nm and 10 ?m, are water-insoluble, have a positive surface charge and a low surface hydrophobicity. The isoelectric point of said particles is greater than 5 to that said particles are present in the lining layer of the lung as positively charged particles, and at the same time higher than the isoelectric point of the pathogenic protein to be bound. Polymer particles of this invention can for example be prepared using the precipitation or emulsion method.
    Type: Application
    Filed: July 18, 2011
    Publication date: June 13, 2013
    Applicant: Justus-Liebig-Universitat Giessen
    Inventors: Moritz Beck-Broichsitter, Thomas Schmehl, Tobias Gessler
  • Patent number: 8431064
    Abstract: The invention relates to supports consisting of nanoscalar polymer fibers, polymer tubes or hollow fibers for the application and targeted and/or delayed release of ingredients, in particular, agricultural active ingredients. The invention also relates to a method and a device for the production of supports of this type in a charged or empty state. The method and device use electrospinning technology.
    Type: Grant
    Filed: August 8, 2011
    Date of Patent: April 30, 2013
    Assignees: Phillips-Universitat Marburg, Justus-Liebig Universitat Giessen
    Inventors: Andreas Greiner, Hans E. Hummel, Joachim H. Wendorff, Mathias Becker, Roland Dersch
  • Publication number: 20130095108
    Abstract: The present invention provides methods for treating interstitial lung diseases, comprising administering to an individual an effective amount of an inhibitor of coagulation factor XII. The invention further provides uses and pharmaceutical kits for that treatment.
    Type: Application
    Filed: April 1, 2011
    Publication date: April 18, 2013
    Applicant: JUSTUS-LIEBIG-UNIVERSITÄT GIESSEN
    Inventors: Ewa Jablonska, Klaus Preissner, Malgorzata Wygrecka
  • Patent number: 8377343
    Abstract: The invention relates to a novel optical function layer and its production, the function layer imparting to materials coated with it protection against uv radiation while transmitting electromagnetic radiation of larger wavelengths. The function layer of the invention and the manufacturing method of the invention offer advantages over the state of the art by allowing very accurate and precise adjustability in the uv range of the relatively sharp absorption constant.
    Type: Grant
    Filed: September 7, 2004
    Date of Patent: February 19, 2013
    Assignee: Justus-Liebig-Universität Giessen
    Inventors: Bruno K. Meyer, Baker Farangis, Detlev Hofmann, Thorsten Krämer, Angelika Polity
  • Patent number: 8338600
    Abstract: The invention at hand describes Cu-(II)-oxygen adduct complexes, which are stable at room temperature, as well as methods for their production. In this, compounds of the general formula [L-Cu—O—O—Cu-L](BAr4)2 are concerned. Here, BAr4? is a tetraarylborate anion, selected from tetraphenylborate and tetrakis(3,5-trifluoromethyl)phenylborate. L represents a tripodal tetradentate ligand, wherein, each of the four binding sites of the tripodal tetradentate ligand is a nitrogen atom. Each of the three podal ligands is suitable for comprising an aliphatic amine or a nitrogen-containing heteroaromatic compound independently of one another. A bridge of one to four carbon atoms is located between the central nitrogen atom and the nitrogen atom of each of the podal ligands. The Cu-(II)-oxygen adduct complexes according to the present invention are produced, by initially reacting the ligand L with a Cu-(I) salt to [Cu-L]X.
    Type: Grant
    Filed: October 27, 2008
    Date of Patent: December 25, 2012
    Assignee: Justus-Liebig-Universitat Giessen
    Inventors: Siegfried Schindler, Christian Würtele
  • Publication number: 20120270942
    Abstract: Disclosed herein is a device for the application of agricultural active agents, wherein the device is suitable to be brought to the site of action in a manner temporally and spatially separated from the production process, and comprises a dispenser and non-water-soluble nanofibers and/or mesofibers charged with agricultural active agents. The polymers from which the nanofibers and/or mesofibers are made are preferably biodegradable. The agricultural active agents are selected from fungicides, herbicides, batericides, plant growth regulators and plant nutrients. These are preferably pheromones, kairomones and signaling substances. Furthermore, a method for the production of this device is disclosed, wherein the nanofibers and/or mesofibers charged with active agents are produced via electrospinning. The device is suitable to be used to bring agricultural active agents to the site of action in a manner temporally and spatially separated from the production of this device.
    Type: Application
    Filed: October 21, 2010
    Publication date: October 25, 2012
    Applicants: Justus-Liebig-Universitat Giessen, Baden-Wurttemberg Versuchs- und Forschungsanstalt fur Weinbau und Weinbehandlung, Philipps-Universitat Marburg
    Inventors: Andreas Greiner, Joachim H. Wendorff, Seema Agarwall, Christoph Hellmann, Michael Breuer, Günter Leithold, Hans E. Hummel, Detlef Hein
  • Patent number: 8288108
    Abstract: A rapid, safe method for predicting sepsis, or a condition similar to sepsis, in a mammal is disclosed, which comprises the following steps: I) isolating RNA from a biological sample of a mammal; ii) labeling the isolated RNA of step I) with a detectable marker; iii) hybridizing the labeled isolated RNA of step ii) with at least one DNA of genes Seq.-ID 1 to Seq.-ID 6705 (Table 1), which is spotted onto a microarray and which is a sepsis-specific gene or gene fragment, under the reaction conditions for hybridizations; iv) quantitatively recording labeling signals of the hybridized RNA of step iii) in an expression profile; v) comparing the expression profile of step iv) with a control sample with respect to a stronger or weaker expression of genes or gene fragments which are specific for sepsis; and vi) combining the expression profile of step v) with protein- and metabolite patterns of the biological sample.
    Type: Grant
    Filed: April 17, 2008
    Date of Patent: October 16, 2012
    Assignee: Justus-Liebig-Universitat Giessen
    Inventors: Hamid Hossain, Trinad Chakraborty, Simon Little, Gregor Bein, Thilo Menges, Svetlin Tchatalbachev